Patient or Physician Preferences for Decision Analysis
- 1 January 1999
- journal article
- other
- Published by SAGE Publications in Medical Decision Making
- Vol. 19 (1) , 66-77
- https://doi.org/10.1177/0272989x9901900109
Abstract
The choice between amniocentesis and chononic villus sampling for prenatal genetic testing involves tradeoffs of the benefits and risks of the tests. Decision analysis is a method of explicitly weighing such tradeoffs. The authors examined the relationship between prenatal test choices made by patients and the choices prescribed by deci sion-analytic models based on their preferences, and separate models based on the preferences of their physicians. Preferences were assessed using written scenarios describing prenatal testing outcomes, and were recorded on linear rating scales. After adjustment for sociodemographic and obstetric confounders, test choice was signifi cantly associated with the choice of decision models based on patient preferences (odds ratio 4.44; CI, 2.53 to 7.78), but not with the choice of models based on the preferences of the physicians (odds ratio 1.60; CI, 0.79 to 3.26). Agreement between decision analyses based on patient preferences and on physician preferences was little better than chance (kappa = 0.085 ± 0.063). These results were robust both to changes in the decision-analytic probabilities and to changes in the model structure itself to simulate non-expected utility decision rules. The authors conclude that patient but not physician preferences, incorporated in decision models, correspond to the choice of amniocentesis or chorionic villus sampling made by the patient. Nevertheless, because patient preferences were assessed after referral for genetic testing, prospec tive preference-assessment studies will be necessary to confirm this association. Key words: decision analysis; patient preferences; physician preferences; prenatal genetic testing. (Med Decis Making 1999;19:66-77)Keywords
This publication has 37 references indexed in Scilit:
- Limb defects and chorionic villus sampling: results from an international registry, 1992-94The Lancet, 1996
- Preferences of pregnant women for amniocentesis or chorionic villus sampling for prenatal testing: Comparison of patients' choices and those of a decision-analytic modelJournal of Clinical Epidemiology, 1994
- Severe limb abnormalities after chorion villus sampling at 56-66 days' gestationThe Lancet, 1991
- The Safety and Efficacy of Chorionic Villus Sampling for Early Prenatal Diagnosis of Cytogenetic AbnormalitiesNew England Journal of Medicine, 1989
- Anxiety reduction after chorionic villus sampling and genetic amniocentesisAmerican Journal of Obstetrics and Gynecology, 1988
- Emotional responses of pregnant women to chorionic villi sampling or amniocentesisAmerican Journal of Obstetrics and Gynecology, 1987
- Chorionic villi sampling: cytogenetic and clinical findings in 500 pregnancies.BMJ, 1987
- Decision AnalysisNew England Journal of Medicine, 1987
- Utility approach to measuring health-related quality of lifeJournal of Chronic Diseases, 1987
- The centralized prenatal genetics screening program of New York City III: The first 7,000 casesAmerican Journal of Medical Genetics, 1985